- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05441436
Neuropsychological and Biopsychosocial Evolution During Pediatric Transplantation: Pre/Post-stages and at 6 Months
June 27, 2022 updated by: Dr. Eduardo Fernández-Jiménez, Hospital Universitario La Paz
Identification of Needs and Neuropsychological and Biopsychosocial Evolution in the Pre/Post-transplant and 6-month Follow-up Phases in Pediatric Population (the TransplantKIDS Mental Health Project)
This pioneering prospective observational study aims to examine biopsychosocial and neuropsychological functioning, care needs and predictors of therapeutic adherence in children/adolescents in pre/post-surgical transplant (solid organ or allogeneic haematopoietic stem cell) phases.
Hypothesis: H1.
Differences in biopsychosocial and neuropsychological functioning and adherence will be observed between transplant types; H2.
Executive functioning will mediate the relationship between anxiety, sleep disturbance and pain intensity/interference and adherence; H3.
There will be a significant improvement in different neuropsychological indicators 6 months post-transplantation. Sample: patients (8-18 years) extracted by non-probabilistic sampling, estimating a sample size of 60 patients (30 for each type of transplant, organ and haematopoietic) from Hospital Universitario La Paz (Madrid).
Individual pre/post-surgical assessments will be carried out (after 2 and 4 weeks), as well as at 6 months post-transplant, both in person (neurocognitive) and through the secure platform REDCap (completed by patients and their legal guardians).
Finally, focus groups will be conducted among patients, their relatives and medical-surgical professionals to identify barriers to therapeutic adherence and unmet care needs during the pre-, peri- and post-surgical process.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eduardo Fernández-Jiménez, PhD
- Phone Number: +34630305521498401
- Email: eduferjim.psyc@gmail.com
Study Locations
-
-
-
Madrid, Spain, 28046
- Recruiting
- Hospital Universitario La Paz. Hospital infantil
-
Contact:
- Eduardo Fernández Jiménez, PhD
- Phone Number: +34630305521498401
- Email: eduferjim.psyc@gmail.com
-
Sub-Investigator:
- María Fe Bravo Ortiz, PhD
-
Sub-Investigator:
- Margarita Alcamí Pertejo, PhD
-
Sub-Investigator:
- Antonio Pérez Martínez, PhD
-
Sub-Investigator:
- Francisco Hernández Oliveros, PhD
-
Sub-Investigator:
- Arancha Ortiz Villalobos, MD
-
Sub-Investigator:
- Jessica Garrido Bolton, MSc
-
Málaga, Spain, 29071
- Active, not recruiting
- University of Malaga
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Potential participants will be all children and adolescents in the imminent phase of being included in the waiting list for a transplant of any solid organ (single or combined), or allogeneic haematopoietic stem cell.
Description
Inclusion Criteria:
- Spanish as mother tongue or a very high level of Spanish in order to understand their participation in the study, as well as to be able to complete the measurement instruments.
Exclusion Criteria:
- Diagnosis of intellectual disability, autism spectrum disorder or acquired brain damage.
- Diagnosis of uncontrolled/stabilised comorbid disease, independent of the disease motivating the transplantation process.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Allogeneic hematopoietic stem cell transplantation
Patients in waiting list for and after allogeneic hematopoietic stem cell transplantation.
|
Allogeneic hematopoietic stem cell transplantation
|
|
Solid organ transplantation
Patients in waiting list for and after solid organ transplantation.
|
Solid organ transplantation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Initial survey created ad hoc
Time Frame: Baseline
|
Both sociodemographic variables (sex, age, patient's level of studies, parents' level of studies) and clinical variables (current pharmacological treatment - active ingredient and dose) will be collected.
|
Baseline
|
|
Behavior Rating Inventory of Executive Function - 2 (BRIEF-2)
Time Frame: Baseline
|
A 63-item questionnaire that assesses patient's executive functions (completed by parents).
Higher scores in each domain indicate a worse outcome.
Spanish norms in T scores (Mean = 50; standard deviation = 10).
|
Baseline
|
|
Behavior Rating Inventory of Executive Function - 2 (BRIEF-2)
Time Frame: 6 months
|
A 63-item questionnaire that assesses patient's executive functions (completed by parents).
Higher scores in each domain indicate a worse outcome.
Spanish norms in T scores (Mean = 50; standard deviation = 10).
|
6 months
|
|
Spanish version of the California Verbal Learning Test for children (TAVECI)
Time Frame: Baseline
|
Assessment of verbal memory in children 3 to 16 years old by the maximum number of remembered elements.
|
Baseline
|
|
Spanish version of the California Verbal Learning Test (TAVEC)
Time Frame: Baseline
|
Assessment of verbal memory for adolescents 16 to 18 years old by the maximum number of remembered elements.
|
Baseline
|
|
Spanish version of the California Verbal Learning Test for children (TAVECI)
Time Frame: 6 months
|
Assessment of verbal memory in children 3 to 16 years old by the maximum number of remembered elements.
|
6 months
|
|
Spanish version of the California Verbal Learning Test (TAVEC)
Time Frame: 6 months
|
Assessment of verbal memory for adolescents 16 to 18 years old by the maximum number of remembered elements.
|
6 months
|
|
Conners Continuous Auditory Test of Attention (CATA)
Time Frame: Baseline
|
It measures auditory sustained attention.
Omissions and commissions are measured for 5 different dimensions: inattentiveness, impulsivity, sustained attention, auditory laterality and auditory mobility.
|
Baseline
|
|
Conners Continuous Auditory Test of Attention (CATA)
Time Frame: 4 weeks
|
It measures auditory sustained attention.
Omissions and commissions are measured for 5 different dimensions: inattentiveness, impulsivity, sustained attention, auditory laterality and auditory mobility.
|
4 weeks
|
|
Conners Continuous Auditory Test of Attention (CATA)
Time Frame: 6 months
|
It measures auditory sustained attention.
Omissions and commissions are measured for 5 different dimensions: inattentiveness, impulsivity, sustained attention, auditory laterality and auditory mobility.
|
6 months
|
|
Test of Nonverbal Intelligence, Fourth Edition (TONI-4) form A
Time Frame: Baseline
|
It assesses intellectual functioning free of cultural influences by the total number of items achieved.
|
Baseline
|
|
Test of Nonverbal Intelligence, Fourth Edition (TONI-4) form B
Time Frame: 6 months
|
It assesses intellectual functioning free of cultural influences by the total number of items achieved.
|
6 months
|
|
Digit span subtests from the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV): Forward, Backward and Sequencing subtests
Time Frame: Baseline
|
It evaluates span of immediate recall and verbal working memory by the total number of items achieved and the maximum number of remembered elements.
|
Baseline
|
|
Digit span subtests from the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV): Forward, Backward and Sequencing subtests
Time Frame: 4 weeks
|
It evaluates span of immediate recall and verbal working memory by the total number of items achieved and the maximum number of remembered elements.
|
4 weeks
|
|
Digit span subtests from the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV): Forward, Backward and Sequencing subtests
Time Frame: 6 months
|
It evaluates span of immediate recall and verbal working memory by the total number of items achieved and the maximum number of remembered elements.
|
6 months
|
|
Vocabulary subtest from the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV)
Time Frame: Baseline
|
It measures semantic memory by the total number of items achieved.
|
Baseline
|
|
Vocabulary subtest from the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) or the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV)
Time Frame: 6 months
|
It measures semantic memory by the total number of items achieved.
|
6 months
|
|
Symbol Digit Modalities Test (SDMT)
Time Frame: Baseline
|
It assesses processing speed by the total number of items achieved.
|
Baseline
|
|
Symbol Digit Modalities Test (SDMT)
Time Frame: 4 weeks
|
It assesses processing speed by the total number of items achieved.
|
4 weeks
|
|
Symbol Digit Modalities Test (SDMT)
Time Frame: 6 months
|
It assesses processing speed by the total number of items achieved.
|
6 months
|
|
The Rey-Osterrieth Complex Figure (ROCF) test
Time Frame: Baseline
|
It measures viso-constructive organisational ability and immediate and delayed visual recall.
One point is awarded for each component that is properly reproduced.
|
Baseline
|
|
The Rey-Osterrieth Complex Figure (ROCF) test
Time Frame: 6 months
|
It measures viso-constructive organisational ability and immediate and delayed visual recall.
One point is awarded for each component that is properly reproduced.
|
6 months
|
|
Fluency Verbal Test (TFV)
Time Frame: Baseline
|
It assesses linguistic-executive functions such as phonological fluency and semantic fluency.
One point is awarded for each word that is correctly produced.
|
Baseline
|
|
Fluency Verbal Test (TFV)
Time Frame: 6 months
|
It assesses linguistic-executive functions such as phonological fluency and semantic fluency.
One point is awarded for each word that is correctly produced.
|
6 months
|
|
Behavioral Assessment System for Children - 3 (BASC-3)
Time Frame: Baseline
|
It measures patients' emotional and behavioural problems, both in its version by the patient's legal guardians and self-reported by the patient.
It is an 139-item report, rated on a 4-point frequency Likert scale.
High scores indicate problematic levels of functioning.
Spanish norms in T scores (Mean = 50; standard deviation = 10).
|
Baseline
|
|
Behavioral Assessment System for Children - 3 (BASC-3)
Time Frame: 6 months
|
It measures patients' emotional and behavioural problems, both in its version by the patient's legal guardians and self-reported by the patient.
It is an 139-item report, rated on a 4-point frequency Likert scale.
High scores indicate problematic levels of functioning.
Spanish norms in T scores (Mean = 50; standard deviation = 10).
|
6 months
|
|
Brief Pain Inventory (BPI)
Time Frame: Baseline
|
This 10-item questionnaire includes questions (from 0 to 10 referring to the last 7 days) covering two dimensions: pain intensity (worst and mildest pain in the week, average pain, and current pain), and pain interference (with general activity, mood, walking, school, sleep, as well as enjoyment of life).
Higher scores on a Likert scale from 0-10 indicate more pain.
|
Baseline
|
|
Brief Pain Inventory (BPI)
Time Frame: 2 weeks
|
This 10-item questionnaire includes questions (from 0 to 10 referring to the last 7 days) covering two dimensions: pain intensity (worst and mildest pain in the week, average pain, and current pain), and pain interference (with general activity, mood, walking, school, sleep, as well as enjoyment of life).
Higher scores on a Likert scale from 0-10 indicate more pain.
|
2 weeks
|
|
Brief Pain Inventory (BPI)
Time Frame: 4 weeks
|
This 10-item questionnaire includes questions (from 0 to 10 referring to the last 7 days) covering two dimensions: pain intensity (worst and mildest pain in the week, average pain, and current pain), and pain interference (with general activity, mood, walking, school, sleep, as well as enjoyment of life).
Higher scores on a Likert scale from 0-10 indicate more pain.
|
4 weeks
|
|
Brief Pain Inventory (BPI)
Time Frame: 6 months
|
This 10-item questionnaire includes questions (from 0 to 10 referring to the last 7 days) covering two dimensions: pain intensity (worst and mildest pain in the week, average pain, and current pain), and pain interference (with general activity, mood, walking, school, sleep, as well as enjoyment of life).
Higher scores on a Likert scale from 0-10 indicate more pain.
|
6 months
|
|
Adolescent Insomnia Questionnaire (AIQ)
Time Frame: Baseline
|
It is a 13-item questionnaire whose original version is in English.
In the present study, this questionnaire will be adapted and validated into Spanish.
Higher scores on a Likert scale from 0-4 indicate more insomnia.
|
Baseline
|
|
Adolescent Insomnia Questionnaire (AIQ)
Time Frame: 2 weeks
|
It is a 13-item questionnaire whose original version is in English.
In the present study, this questionnaire will be adapted and validated into Spanish.
Higher scores on a Likert scale from 0-4 indicate more insomnia.
|
2 weeks
|
|
Adolescent Insomnia Questionnaire (AIQ)
Time Frame: 4 weeks
|
It is a 13-item questionnaire whose original version is in English.
In the present study, this questionnaire will be adapted and validated into Spanish.
Higher scores on a Likert scale from 0-4 indicate more insomnia.
|
4 weeks
|
|
Adolescent Insomnia Questionnaire (AIQ)
Time Frame: 6 months
|
It is a 13-item questionnaire whose original version is in English.
In the present study, this questionnaire will be adapted and validated into Spanish.
Higher scores on a Likert scale from 0-4 indicate more insomnia.
|
6 months
|
|
Pediatric Sleep Disturbances Short Form (PROMIS)
Time Frame: Baseline
|
A 4-item questionnaire that assesses problems with sleep reconciliation and sleep maintenance in the last 7 days.
Higher scores on a Likert scale from 1-5 indicate worse sleep.
|
Baseline
|
|
Pediatric Sleep Disturbances Short Form (PROMIS)
Time Frame: 2 weeks
|
A 4-item questionnaire that assesses problems with sleep reconciliation and sleep maintenance in the last 7 days.
Higher scores on a Likert scale from 1-5 indicate worse sleep.
|
2 weeks
|
|
Pediatric Sleep Disturbances Short Form (PROMIS)
Time Frame: 4 weeks
|
A 4-item questionnaire that assesses problems with sleep reconciliation and sleep maintenance in the last 7 days.
Higher scores on a Likert scale from 1-5 indicate worse sleep.
|
4 weeks
|
|
Pediatric Sleep Disturbances Short Form (PROMIS)
Time Frame: 6 months
|
A 4-item questionnaire that assesses problems with sleep reconciliation and sleep maintenance in the last 7 days.
Higher scores on a Likert scale from 1-5 indicate worse sleep.
|
6 months
|
|
Simplified Medication Adherence Questionnaire (SMAQ)
Time Frame: Baseline
|
A 6-item self-report that measures adherence to medication.
For items 1-4 yes or no answers are required.
Item 5 requires a multiple choice answer in terms of frequency (5 different options are provided).
Item 6 requires a number input.
The final score is a dichotomous variable: non-adherent versus adherent patient.
|
Baseline
|
|
Simplified Medication Adherence Questionnaire (SMAQ)
Time Frame: 2 weeks
|
A 6-item self-report that measures adherence to medication.
For items 1-4 yes or no answers are required.
Item 5 requires a multiple choice answer in terms of frequency (5 different options are provided).
Item 6 requires a number input.
The final score is a dichotomous variable: non-adherent versus adherent patient.
|
2 weeks
|
|
Simplified Medication Adherence Questionnaire (SMAQ)
Time Frame: 4 weeks
|
A 6-item self-report that measures adherence to medication.
For items 1-4 yes or no answers are required.
Item 5 requires a multiple choice answer in terms of frequency (5 different options are provided).
Item 6 requires a number input.
The final score is a dichotomous variable: non-adherent versus adherent patient.
|
4 weeks
|
|
Simplified Medication Adherence Questionnaire (SMAQ)
Time Frame: 6 months
|
A 6-item self-report that measures adherence to medication.
For items 1-4 yes or no answers are required.
Item 5 requires a multiple choice answer in terms of frequency (5 different options are provided).
Item 6 requires a number input.
The final score is a dichotomous variable: non-adherent versus adherent patient.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Eduardo Fernández-Jiménez, PhD, Hospital Universitario La Paz
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 26, 2022
Primary Completion (Anticipated)
May 26, 2025
Study Completion (Anticipated)
May 26, 2025
Study Registration Dates
First Submitted
June 13, 2022
First Submitted That Met QC Criteria
June 27, 2022
First Posted (Actual)
July 1, 2022
Study Record Updates
Last Update Posted (Actual)
July 1, 2022
Last Update Submitted That Met QC Criteria
June 27, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 5223
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transplant-Related Disorder
-
Institute of Hematology & Blood Diseases Hospital...RecruitingTransplant-Related DisorderChina
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingTransplant-Related Disorder
-
Institute of Hematology & Blood Diseases Hospital...RecruitingTransplant-Related DisorderChina
-
University of Wisconsin, MadisonTerminatedNeoplasm | Transplant-Related Disorder | Oral MucosaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedEBV-Related Post-Transplant Lymphoproliferative Disorder | Monomorphic Post-Transplant Lymphoproliferative Disorder | Polymorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Polymorphic Post-Transplant Lymphoproliferative... and other conditionsUnited States
-
Victor AquinoAvailableTransplant-Related Disorder | GVH - Graft Versus Host ReactionUnited States
-
Medical University of ViennaCompletedTransplant-Related Disorder
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation in ChildrenCompletedLiver Transplant | Kidney Transplant | Heart Transplant | EBV-Related PTLD | Small Intestine Transplant | PTLDsUnited States
-
Timothy VoorheesAbbVie; GenmabRecruitingEBV-Related Post-Transplant Lymphoproliferative Disorder | Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder | Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder | Refractory Polymorphic... and other conditionsUnited States
-
Min Suk ChaeNot yet recruitingLiver Transplant Disorder
Clinical Trials on Allogeneic hematopoietic stem cell transplantation
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedAcute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Minimal Residual Disease | Therapy-Related Acute Myeloid Leukemia | Therapy-Related Myelodysplastic... and other conditionsUnited States
-
Wake Forest University Health SciencesCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Karolinska InstitutetKarolinska University HospitalTerminatedPancreatic AdenocarcinomaSweden
-
The First Affiliated Hospital of Soochow UniversityRecruitingMDS (Myelodysplastic Syndrome) | Relapsed or Refractory Acute Myeloid Leukemia (AML)China
-
Hadassah Medical OrganizationUnknown
-
Northwestern UniversityTerminated
-
Ruijin HospitalRecruiting
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Institute of Hematology & Blood Diseases HospitalRecruiting
-
Donghua ZhangNot yet recruitingAML | AML (Acute Myeloid Leukemia)China